Free Trial
→ Now I look stupid. Real stupid... (From Porter & Company) (Ad)

15 Healthcare Stocks that Analysts Love in a Post-Pandemic World - 14 of 15

Slide 14
Back to 13
Continue to 15
 
Back to 13
Continue to 15
 

Legend Biotech (NASDAQ:LEGN)

Consensus Rating
Moderate Buy
Rating Score
2.9
Ratings Breakdown
11 Buy Ratings, 1 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$79.00 (145.0% Upside)

About Legend Biotech

Legend Biotech logoLegend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery, development, manufacturing, and commercialization of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multiple myeloma (MM). More about Legend Biotech
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
4/16/2025HC WainwrightReiterated RatingBuy ➝ Buy$75.00 ➝ $75.00
4/8/2025HC WainwrightReiterated RatingBuy ➝ Buy$75.00 ➝ $75.00
3/17/2025Morgan StanleyLower Price TargetOverweight ➝ Overweight$82.00 ➝ $80.00
3/12/2025GuggenheimReiterated RatingNeutral ➝ Neutral
3/12/2025HC WainwrightBoost Price TargetBuy ➝ Buy$73.00 ➝ $75.00
1/21/2025HC WainwrightReiterated RatingBuy ➝ Buy$73.00 ➝ $73.00
12/30/2024Piper SandlerReiterated RatingOverweight ➝ Overweight$78.00 ➝ $78.00
12/10/2024HC WainwrightReiterated RatingBuy ➝ Buy$73.00 ➝ $73.00
12/9/2024Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$83.00 ➝ $83.00
12/9/2024Royal Bank of CanadaReiterated RatingOutperform ➝ Outperform$86.00 ➝ $86.00
Slide 14
Back to 13
Continue to 15
 

More From MarketBeat
Elon Set to Shock the World by May 1st ?
Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...
Brownstone Research | Sponsored
The 10 Best Lithium Stocks to Buy for a Post Gasoline World
Electric vehicles currently make up about 5% of new car sales in the United States. While they have received a...
MarketBeat
[Action Required] Claim Your FREE IRS Loophole Guide
This shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...
Colonial Metals | Sponsored
15 Healthcare Stocks that Analysts Love in a Post-Pandemic World
There are more than 200 healthcare companies traded on public markets. Given the sheer number of pharmaceutica...
MarketBeat
Now I look stupid. Real stupid...
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...
Porter & Company | Sponsored
7 Large-Cap Stocks Poised for Strong, Steady Gains in 2025
Growth stocks have outperformed value stocks in 2024 and are likely to continue to do so in 2025. Two reason...
MarketBeat